title: [Acute transverse myelitis].
abstract: Acute transverse myelopathy (ATM) is a large group from various etiologies including multiple sclerosis, systemic diseases, post-infectious myelopathy, spinal cord infarct and neuromyelitis optica. In about 20% of cases, the etiology remains unknown even after a long-term follow-up. We call these cases "idiopathic ATM". The poor prognosis of ATM makes necessary an early diagnosis to avoid therapeutic delay. The aim of this review is to describe clinical and laboratory data concerning ATM allowing to improve diagnostic and therapeutic approaches.
authors.affiliation: Clinique neurologique, CHU de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg cedex, France. jerome.de.seze@chru-strasbourg.fr
authors.forename: J
authors.initials: J
authors.lastname: de Sèze
mesh_terms: D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications; D009187:Myelitis / Q000150:complications; D009188:Myelitis, Transverse / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D009471:Neuromyelitis Optica / Q000150:complications; D011379:Prognosis; D012307:Risk Factors; D020760:Spinal Cord Ischemia / Q000150:complications
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D007372:Interferons